Sanbio B.V., based in Uden (the Netherlands) and established in 1978, is an independent supplier of life science products for research and diagnostics in the Benelux and represents a large number of innovative international companies. Sanbio is also manufacturer and developer of antibodies and antibody-related products of its own brand Monosan, suitable for basic and applied life sciences projects. Our strong reputation is built on our aim to serve our customers with the highest level of service and support.
In 2007 Sanbio moved into a brand new state of art facility with room for growth. We are located in the Eindhoven region which is the brightest region in the world as appointed by the Intelligent Community Forum (ICF). It is centrally located and close to high technology science parks in Eindhoven, Utrecht and Nijmegen. This enables technology transfer in the process of knowledge, skill transferring and methods of manufacturing among institutions to ensure that scientific and technological developments are accessible to a wider range of users.
The laboratory products Sanbio supplies for life science and diagnostics are carefully selected to meet the standards set for reliability, applicability, quality and innovation. Sharing the experience and knowledge, gathered by Sanbio in the past 35 years, has resulted in mutually respected partnerships between Sanbio, their suppliers and end-users. For Sanbio, quality-oriented thinking, good communication, reliability, technical skills and market intelligence are well integrated core concepts within the organization.
Sanbio acts as link between user and supplier of laboratory products for life science and diagnostics. By keeping communication lines short and sharing technical knowledge, it’s easier for the customer (technicians, specialists and procurement officers) to gain access to the products offered by Sanbio. This contributes to high levels of fundamental and applied research performed within the Benelux countries, which ultimately benefits to progression of health care in general.
Our customers in Belgium, the Netherlands and Luxembourg (Benelux) are based in laboratories of academic hospitals, universities, general hospitals, governmental laboratories, contract research organizations, pharmaceutical – and biotech industry.
We regularly visit international congresses and business meetings to learn more about the trends in the life science market through conversations with experts, business networking, and educational sessions. We always come back with renewed energy and inspiration, because of the wealth of new information we gained. This helps us to stay on top of the developments within a fast moving market.
The online word of mouth by social media, our interactive website, search engine optimization and sending out digital newsletters gives us different ways to share and promote new developments, new products and innovations, from either our suppliers or our own products, with our customers. A direct sales force in the field serves our customers with a high level of technical expertise and hands on experience.
Our continuous efforts to improve our high standard of quality and support is part of a certified ISO9001 quality system. We implemented this quality system back in 1997 as one of the first biotech companies in the Netherlands. Feedback from our customers has proven to be of major importance in planning and executing projects for improved logistics and faster customer support.
MONOSAN®, the brand name of Sanbio, is our own product line with commercially available antibodies and antibody-related products. The Monosan portfolio contains over 3000 monoclonal and polyclonal antibodies and reagents which are being developed and commercialized either in our own laboratories or in collaboration with some of the leading universities and research institutes throughout Europe and the United States. Monosan products are marketed and sold worldwide through a network of approved and service-conscious distributors and OEM partners in more than 70 different countries. A complete range of highly specific and exclusive antibodies is brought together at our website: www.monosan.com
Research and diagnostics within molecular biology are upcoming. We focus on innovative products and techniques, such as Next-Generation Sequencing, gene based research, DNA/RNA isolation from difficult samples, full length cDNA clones, epigenetic solutions etc.
Traditionally Sanbio holds a strong position in the immunology market. Our portfolio currently exists of over 90.000 different antibodies, ELISA kits, proteins and additional products from well-established suppliers. Sanbio was one of the first companies to supply a monoclonal antibody for life science.
The cellular biology market is one of the fastest growing markets within life science. Our cell biology product line exists of specific primary cell lines with associated media, exclusive growth factors, cell based assays, and transfection reagents to support research of fundamental cellular processes.
Success in life science demands excellence in every dimension. This includes labware and consumables you trust for consistent, reliable results. Products from NUNC and Nalgene, part of Thermo Fisher, belong to our portfolio and are committed to the highest quality standards from product materials and manufacturing methods, to customer support.
Sanbio has an extensive knowledge and experience within pathology. Not only because of our outstanding portfolio of suppliers, but also our product specialists are highly experienced in this field by training and education.
Diagnostic testing is used to determine the causes of symptoms of diseases. Our suppliers, excellent in diagnostic testing, are selected to improve the quality of life for patients and their family.
A large part of our portfolio of products for HLA typing and screening, auto immune diagnostics, molecular diagnostics and infectious diseases is based upon the Luminex technology, now complemented with upcoming techniques such as qPCR and Next- Generation Sequencing.
Sanbio has a strong cooperation with Hycult Biotech (www.hycultbiotech.com) which was founded in 1994 and is based at the same location. Hycult Biotech develops, produces and markets antibodies, antibody-based products and more specific immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.
VAT number: NL008855523B02